Table 1.
Characteristics of Included Studies
| Study* | Full study name | Country† | n T2DM / nondiabetic subjects‡ |
|---|---|---|---|
| BOTNIA | Botnia Study | SF | 731/557 |
| CAPPP | Captopril Prevention Project | S | 42/424 |
| DANISH | Danish Study | DK | 1212/4399 |
| EDSC | Ealing Diabetes Study of Coagulation | UK | 299/0 |
| EPIC- POTSDAM | European Prospective Investigation into Cancer and Nutrition Potsdam (EPIC-Potsdam) | D | 0/348 |
| FUSION 1 | The Finland-United States Investigation of NIDDM Genetics, 1st sampling wave | SF | 508/367 |
| FUSION 2 | The Finland-United States Investigation of NIDDM Genetics, 2nd sampling wave | SF | 437/201 |
| GIRONA | Girona Genetics of Diabetes Study | E | 42/123 |
| KORA- MIFAM | KORA MI Family Study | D | 95/881 |
| KORA-S4 | KORA Survey S4 | D | 225/1190 |
| KORA- T2DMFAM | KORA T2DM Family Study | D | 776/513 |
| MONICA/ KORA-BASE | MONICA/KORA Case Cohort Study S123(MONICA/KORA-S123) | D | 101/1744 |
| MONICA-S3 | MONICA/KORA Survey S3 | D | 151/3551 |
| NPHS II | Second Northwick Park Heart Study | UK | 0/2652 |
| RMIFAM | Regensburg Ml Family Study | D | 662/2614 |
| TGN | Tarraco Study | E | 166/64 |
| UDACS | University College Diabetes and Cardiovascular Study | UK | 560/0 |
MI = Myocardial Infarction
*
Abbreviated study name used in the present publication
†
Country of recruitment: D = Germany, DK = Denmark, E = Spain, SF = Finland, S = Sweden, UK = United Kingdom
‡
Number of type 2 diabetic / nondiabetic subjects included in analyses of the outcome BMI